| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/08/2004 | WO2003104473A8 Galactosyl isomalt, method for production and use thereof |
| 04/08/2004 | WO2003104428A3 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/08/2004 | WO2003102207A3 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 04/08/2004 | WO2003101530A3 Solid hydrogel coupling for ultrasound imaging and therapy |
| 04/08/2004 | WO2003100087A3 Regulation of novel human asparagine-hydroxylases |
| 04/08/2004 | WO2003100008A3 Neutralizing human anti-igfr antibody |
| 04/08/2004 | WO2003099218A3 Anti-cancer formulation |
| 04/08/2004 | WO2003095459A3 Alkaloid-derived compounds and use thereof in cancer and malaria treatment |
| 04/08/2004 | WO2003092605A9 Protease inhibitors |
| 04/08/2004 | WO2003086314A3 Tyrosine kinase inhibitors |
| 04/08/2004 | WO2003084611A8 Depsipeptide for therapy of kidney cancer |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003076602A3 Use of l-$g(a)-lysophosphatidycholine to obtain the differentiation of monocytes in mature dendritric cells in vivo |
| 04/08/2004 | WO2003075956A3 Use of mixtures of lipopeptides for vaccine production |
| 04/08/2004 | WO2003074060A3 Dna demethylase antisense and chemotherapy combination |
| 04/08/2004 | WO2003072820A3 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 04/08/2004 | WO2003068140A3 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same |
| 04/08/2004 | WO2003066077A3 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 04/08/2004 | WO2003065006A3 Methods and compositions for treating cancer |
| 04/08/2004 | WO2003063893A3 Fgfr agonists |
| 04/08/2004 | WO2003046581A3 Methods for diagnosis and treatment of epithelial-derived cancers,such as colorectal cancers and kidney cancers |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | WO2003014300A3 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/08/2004 | WO2003011313A8 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 04/08/2004 | WO2003009881A3 Novel targeted delivery system for bioactive agents |
| 04/08/2004 | WO2003003806A3 Dye-azide compounds for dual phototherapy |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002081668A9 Desaturase genes and uses thereof |
| 04/08/2004 | WO2002076173A3 Inhibitors of glycosaminoglycans |
| 04/08/2004 | WO2002058546A3 Methods for screening for substances which inhibit fp prostanoid receptor |
| 04/08/2004 | WO2002030470A8 Methods and compositions for nucleic acid delivery |
| 04/08/2004 | US20040068207 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 04/08/2004 | US20040068129 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength |
| 04/08/2004 | US20040068108 Disaccharide sequences formed by uronic acid and hexose as to form polysaccharides of 8-24 monosaccharide units whose hydroxyl groups are substituted by alkyl or sulphate groups; possible to modulate activities of glycosaminoglycans type |
| 04/08/2004 | US20040068039 PVA embolic materials are prepared through saponifying poly(vinyl pivalate) |
| 04/08/2004 | US20040067990 Thiazolyl inhibitors of Tec family tyrosine kinases |
| 04/08/2004 | US20040067989 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents |
| 04/08/2004 | US20040067987 Antiarthritic agents; osteoporosis; anticancer agents |
| 04/08/2004 | US20040067979 N-bridged selective androgen receptor modulators and methods of use thereof |
| 04/08/2004 | US20040067969 Syntheses of quinazolinones |
| 04/08/2004 | US20040067968 Antitumor, anticancer agents |
| 04/08/2004 | US20040067954 Benzoylpyridazines |
| 04/08/2004 | US20040067953 Combination therapy for treating, preventing or managing proliferative disorders and cancers |
| 04/08/2004 | US20040067952 Method and composition for treatment of cancer |
| 04/08/2004 | US20040067951 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof |
| 04/08/2004 | US20040067949 Substituted indoles which are parp inhibitors |
| 04/08/2004 | US20040067943 Tryptase inhibitors |
| 04/08/2004 | US20040067942 Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies |
| 04/08/2004 | US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067924 Actinium-225 complexes and conjugates for targeted radiotherapy |
| 04/08/2004 | US20040067918 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 04/08/2004 | US20040067912 Microbiocides, antibiotic, antitumor agent |
| 04/08/2004 | US20040067900 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| 04/08/2004 | US20040067895 Molluscs extract; anticancer agents |
| 04/08/2004 | US20040067893 Adenocarcinogenic agent |
| 04/08/2004 | US20040067892 Fullerene derivative and composition comprising the same |
| 04/08/2004 | US20040067885 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer |
| 04/08/2004 | US20040067883 Prevent gene expression; anticancer agents |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067541 Detectable levels of fucosylation change in Prostate Specific Antigen when the prostate is cancerous; Labeled ulex lectin; kits |
| 04/08/2004 | US20040067527 A conjugate of an acrylamide based polymer, capable of being taken up by a cell, linked to a biologically active polypeptides and conjugate capable of intracellular delivery of polypeptide while retaining its activity |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067491 Diagnosis of diseases associated with metabolism |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067263 Treatment of liver cancer, adenocarcinoma of stomach, lung cancer, and breast carcinoma. |
| 04/08/2004 | US20040067257 Pharmaceutical formulation |
| 04/08/2004 | US20040067256 Novel modified release formulation |
| 04/08/2004 | US20040067252 Novel modified release formulation |
| 04/08/2004 | US20040067240 Therapeutic agent comprising a b-subunit of a protein toxin |
| 04/08/2004 | US20040067228 O-acetyl-ADP ribose, a histone deacetylase-reaction product, used for producing polyclonal or monoclonal antibodies, and for analysis by competitive binding assaying of aging resistance and/or anticarcinogenic agents |
| 04/08/2004 | US20040067218 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissue |
| 04/08/2004 | US20040067199 Conjugates with radionuclides; radiotherapy; tumor diagnosis |
| 04/08/2004 | CA2499972A1 Method for inducing mammary epithelial cell differentiation |
| 04/08/2004 | CA2499819A1 Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 04/08/2004 | CA2498787A1 Antibody for adcc and inducing cytokine production |
| 04/08/2004 | CA2498383A1 Treatment of pathologies which escape the immune response, using optimised antibodies |
| 04/08/2004 | CA2497765A1 8-hydroxy substituted adenine compounds and uses thereof |
| 04/08/2004 | CA2494899A1 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/07/2004 | EP1405862A2 Method for the identification of antigenic peptides |
| 04/07/2004 | EP1405860A1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/07/2004 | EP1405855A1 A kind of oligosaccharides, their sulfates and dendrimers, and the uses of these compounds |
| 04/07/2004 | EP1405645A1 Remedies for eosinophilic diseases |
| 04/07/2004 | EP1405083A2 Natural ligand of gpcr chemr23 and uses thereof |
| 04/07/2004 | EP1405079A2 Modulation of the interaction between evh1 domains |
| 04/07/2004 | EP1405074A2 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1404876A2 Interferon alpha-14 polymorphism |
| 04/07/2004 | EP1404874A2 Screening method |
| 04/07/2004 | EP1404871A2 Method for treatment of cancer associated with elevated her 2 levels |
| 04/07/2004 | EP1404864A2 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 04/07/2004 | EP1404863A1 PIBs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 04/07/2004 | EP1404860A2 Delivery system for nucleic acids |
| 04/07/2004 | EP1404841A2 Cyp1b1 nucleic acids and methods of use |
| 04/07/2004 | EP1404831A2 Type 2 cytokine receptor and nucleic acids encoding same |
| 04/07/2004 | EP1404817A2 Use of oxidised lipoproteins for differentiation of precursor cells into mature dendritic cells |
| 04/07/2004 | EP1404714A2 Nuclear hormone receptor ligand binding domain |
| 04/07/2004 | EP1404703A2 G-protein coupled receptors |
| 04/07/2004 | EP1404682A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 04/07/2004 | EP1404678A1 Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture |